Boyce Sarah — SEC insider filings

SEC reporting owner CIK 1629383. 44 insider filings on record with FilingPulse; latest filed 2026-09-22.

Transaction summary — filings shown

Covers all 44 filings on record, filed 2021-02-04 to 2026-09-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avidity Biosciences, Inc. (RNAM)President and CEO, Director28—29 legs · 977,801 sh · $33,085,74662
Berkeley Lights, Inc. (BLI)Director2—3 legs · 10,000 sh · $611,3374
OmniAb, Inc. (OABI)Director62 legs · 36,000 sh · $101,397—14
LIGAND PHARMACEUTICALS INC (LGND)—3——6
Contineum Therapeutics, Inc. (CTNM)Director3——3
Atrium Therapeutics, Inc. (RNA)Director2——2

Insider filings — Boyce Sarah

FiledFormIssuerReported transactionsSource
2026-09-224Atrium Therapeutics, Inc. (RNA)Tax withholding (F): 126,418 @ $8.95EDGAR
2026-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2026-03-024Atrium Therapeutics, Inc. (RNA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-02-274Avidity Biosciences, Inc. (RNAM)Disposition to issuer (D): 474,861 · Disposition to issuer (D): 386,015 (derivative) · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 425,000 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 200,000 (derivative) · +2 moreEDGAR
2026-01-234Avidity Biosciences, Inc. (RNA)Sale (S): 6,394 @ $72.45 · Sale (S): 7,993 @ $72.45EDGAR
2026-01-094Avidity Biosciences, Inc. (RNA)Sale (S): 8,576 @ $72.23EDGAR
2025-12-194Avidity Biosciences, Inc. (RNA)Grant/award (A): 31,000 @ $0 · Tax withholding (F): 15,742 @ $71.87 · Gift (G): 29,159 @ $0EDGAR
2025-09-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 50,000 @ $1.24 · Sale (S): 50,000 @ $49.95 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-08-294Avidity Biosciences, Inc. (RNA)Option exercise (M): 25,000 @ $1.24 · Sale (S): 25,000 @ $49.39 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-06-264Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 14,750 (derivative) @ $0EDGAR
2025-03-214Avidity Biosciences, Inc. (RNA)Sale (S): 31,540 @ $31.06EDGAR
2025-01-234Avidity Biosciences, Inc. (RNA)Sale (S): 4,738 @ $28.59 · Sale (S): 5,659 @ $28.59EDGAR
2025-01-084Avidity Biosciences, Inc. (RNA)Grant/award (A): 82,500 @ $0 · Grant/award (A): 165,000 (derivative) @ $0EDGAR
2024-12-194Avidity Biosciences, Inc. (RNA)Sale (S): 31,855 @ $32.66EDGAR
2024-09-234Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 32,880 @ $44.00 · Grant/award (A): 62,500 @ $0EDGAR
2024-08-074Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $43.35 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-07-114Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $39.93 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-06-244Contineum Therapeutics, Inc. (CTNM)Grant/award (A): 29,500 (derivative) @ $0EDGAR
2024-06-214OmniAb, Inc. (OABI)Option exercise (M): 20,000 · Option exercise (M): 20,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-204Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 32,074 @ $39.13 · Grant/award (A): 62,500 @ $0EDGAR
2024-06-144Avidity Biosciences, Inc. (RNA)Option exercise (M): 100,000 @ $1.24 · Sale (S): 100,000 @ $35.73 · Option exercise (M): 164,233 @ $1.24 · Sale (S): 164,233 @ $40.08 · Option exercise (M): 35,767 @ $1.24 · Sale (S): 35,767 @ $40.08 · +3 moreEDGAR
2024-06-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $27.42 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-05-074Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $25.54 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-04-234/AOmniAb, Inc. (OABI)Grant/award (A): 39,628EDGAR
2024-04-034Avidity Biosciences, Inc. (RNA)Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $26.25 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-03-124Avidity Biosciences, Inc. (RNA)Option exercise (M): 84,000 @ $1.24 · Sale (S): 84,000 @ $21.39 · Option exercise (M): 28,000 @ $1.24 · Sale (S): 28,000 @ $22.63 · Option exercise (M): 84,000 (derivative) @ $0 · Option exercise (M): 28,000 (derivative) @ $0EDGAR
2024-03-054Avidity Biosciences, Inc. (RNA)Option exercise (M): 84,000 @ $1.24 · Sale (S): 84,000 @ $20.13 · Option exercise (M): 84,000 (derivative) @ $0EDGAR
2024-01-234Avidity Biosciences, Inc. (RNA)Grant/award (A): 62,500 @ $0 · Sale (S): 5,092 @ $10.13 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2023-09-124Avidity Biosciences, Inc. (RNA)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2023-06-274OmniAb, Inc. (OABI)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-02-034Avidity Biosciences, Inc. (RNA)Option exercise (M): 900 @ $1.24 · Sale (S): 900 @ $24.27 · Option exercise (M): 45,879 @ $1.24 · Sale (S): 45,879 @ $24.36 · Option exercise (M): 3,221 @ $1.24 · Sale (S): 3,221 @ $24.26 · +3 moreEDGAR
2023-02-014OmniAb, Inc. (OABI)Grant/award (A): 8,753 @ $0 · Grant/award (A): 37,840 (derivative) @ $0EDGAR
2023-01-244Avidity Biosciences, Inc. (RNA)Grant/award (A): 50,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0EDGAR
2022-11-144OmniAb, Inc. (OABI)Purchase (P): 21,000 @ $2.74 · Purchase (P): 15,000 @ $2.92EDGAR
2022-11-034LIGAND PHARMACEUTICALS INC (LGND)Disposition to issuer (D): 1,004 · Disposition to issuer (D): 4,340 (derivative)EDGAR
2022-11-034OmniAb, Inc. (OABI)Grant/award (A): 37,437 · Grant/award (A): 22,616 (derivative) · Grant/award (A): 10,565 (derivative) · Grant/award (A): 13,994 (derivative) · Grant/award (A): 37,840 (derivative)EDGAR
2022-08-264Avidity Biosciences, Inc. (RNA)Option exercise (M): 35,045 @ $1.24 · Sale (S): 35,045 @ $22.80 · Option exercise (M): 14,855 @ $1.24 · Sale (S): 14,855 @ $23.07 · Option exercise (M): 35,045 (derivative) @ $0 · Option exercise (M): 14,855 (derivative) @ $0EDGAR
2022-08-174Avidity Biosciences, Inc. (RNA)Option exercise (M): 100 @ $1.24 · Sale (S): 100 @ $22.47 · Option exercise (M): 100 (derivative) @ $0EDGAR
2022-06-134LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,004 @ $0 · Grant/award (A): 4,340 (derivative) @ $0EDGAR
2022-03-154Avidity Biosciences, Inc. (RNA)Grant/award (A): 425,000 (derivative) @ $0EDGAR
2021-06-074LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 630 @ $0 · Grant/award (A): 3,269 (derivative) @ $0EDGAR
2021-05-184Berkeley Lights, Inc. (BLI)Grant/award (A): 1,400 @ $0 · Grant/award (A): 4,900 (derivative) @ $0EDGAR
2021-03-034Berkeley Lights, Inc. (BLI)Option exercise (M): 10,000 @ $8.90 · Sale (S): 3,773 @ $60.08 · Sale (S): 3,000 @ $61.13 · Sale (S): 3,227 @ $62.37 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-02-044Avidity Biosciences, Inc. (RNA)Grant/award (A): 300,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1629383 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs